BC
BNTX icon

Bayforest Capital’s BioNTech BNTX Stock Holding History

Bayforest Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,275
Closed -$113K – 975
2026
Q1 		$113K Sell
1,275
-2,281
-64% -$234K 0.13% 317
2025
Q4 		$339K Buy
+3,556
New +$358K 0.25% 95
2025
Q1 		– Sell
-443
Closed -$50.5K – 742
2024
Q4 		$50.5K Buy
+443
New +$50.6K 0.06% 470

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Bayforest Capital's BNTX Position: Q2 2026 in Review

Bayforest Capital sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 1,275 shares — an estimated $113K sold.

Bayforest Capital first reported a position in BNTX in Q4 2024 and held it in 3 quarters. The position peaked at $339K in Q4 2025. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Bayforest Capital reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Bayforest Capital sold 1,275 BioNTech shares in Q2 2026, an estimated $113K.
  • Bayforest Capital first reported a position in BioNTech in Q4 2024 and held it in 3 quarters.
  • Bayforest Capital's BioNTech position peaked at $339K in Q4 2025.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.